Europe — EMA

Pamifos (Pamidronate Disodium)

Request sourcing

Pack/s

What is Pamidronate Disodium?

Pamidronate disodium, the active ingredient in Pamifos, is a bisphosphonate presented as a intravenous solution for intravenous use. It treats bone loss conditions such as hypercalcemia of malignancy and Paget's disease of bone in adult patients. GNH USA supplies Pamifos as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and oncology centres worldwide.

GNH USA supplies Pamifos as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and oncology centres worldwide.

What is Pamidronate Disodium used for?

Pamifos is a bisphosphonate that acts on disorders of bone remodeling.

- Hypercalcemia of malignancy: helps ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... - Paget ... ... ... ... ... ... ...

What are the side effects of Pamidronate Disodium?

Pamifos .... … ... ....... … ... ... ... .... … ... … ...

What precautions apply to Pamidronate Disodium?

Pamifos …

What does Pamidronate Disodium interact with?

....

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →